Loading
Life sciences · Journal article
Vnu Journal of Science Medical and Pharmaceutical Sciences · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Nanostructured Lipid Carriers (NLC) are a new generation of lipid-based nanocarrier systems composed of a mixture of solid and liquid lipids, forming a less ordered lipid matrix compared to Solid Lipid Nanoparticles (SLNs). Due to this structural characteristic, NLC exhibit improved drug loading capacity, enhanced stability, controlled drug release, and increased bioavailability. In addition, NLC possess several advantages, including high biocompatibility, biodegradability, and improved permeation across biological barriers. However, this system still presents certain limitations, such as polymorphic instability, formulation challenges, and insufficient long-term safety data. Currently, NLC have been widely investigated and applied in pharmaceutical fields through various administration routes, including oral, injectable, transdermal, nasal, and ocular delivery, while also demonstrating potential in gene delivery and cancer therapy. Owing to these promising characteristics, NLC are considered one of the most potential nanocarrier systems in modern pharmaceuticals.